Fostair (beclometasone/formoterol): key messages
This promotional resource has been commissioned and developed by Chiesi Limited. Information intended for UK healthcare professionals only.
Fostair NEXThaler is indicated for the regular treatment of asthma in adults where use of a combination product (inhaled corticosteroid and long-acting β2 -agonist) is appropriate: patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β2 -agonist or patients already adequately controlled on both inhaled corticosteroids and long-acting β2 -agonist.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.